Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.14 USD | +0.50% | +0.83% | +4.37% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 7.43 and 8.54 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- This company will be of major interest to investors in search of a high dividend stock.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Closed End Funds
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.37% | 672M | - | ||
+7.69% | 13.26B | C | ||
+11.85% | 9.55B | - | C- | |
+2.65% | 5.74B | D+ | ||
+7.30% | 5.27B | - | - | |
-0.71% | 5.11B | - | D | |
+26.36% | 4.99B | - | - | |
+20.18% | 4.59B | - | - | |
+1.45% | 3.98B | - | ||
+5.29% | 3.97B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CCAP Stock
- Ratings Crescent Capital BDC, Inc.